Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device

Creative Commons License

Ferrari M., Kadipasaoglu K., Croitoru M., Conger J., Myers T., Gregoric I., ...More

JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol.24, no.2, pp.226-228, 2005 (SCI-Expanded) identifier identifier identifier


In 2 patients with the Jarvik 2000 left ventricular assist device (LVAD), we assessed left ventricular systolic function through pressure-volume loops and E-max at the beginning and end of the support period to potentially predict the possibility of pump removal without transplantation. Immediately before LVAD implantation and explantation, pressure, and volume measurements were made with catheters. and echocardiography, respectively, the E-max being calculated from the slope of the pressure-volume loops, and the left ventricular ejection fraction (LVEF) being estimated by echocardiography. Transplantation was performed after 14 and 62 days, respectively, during which the LVEF increased by 75% (from 12% to 21%) in Patient 1 and remained unchanged. (from 1.6% to 18%) in Patient 2, whereas the E-max increased from 0.63 and 0.42 mm Hg/ml, respectively, to 1.31 and 1.07 mm Hg/ml, reflecting a 107% and 155% improvement. In these 2 cases, the E-max was a more reliable indicator of intrinsic myocardial contractility than was the LVEF. Copyright (C) 2005 by the International Society for Heart and Lung Transplantation.